MRC Molecular Haematology Unit
At the MRC Molecular Haematology Unit, we aim to understand how stem cells produce mature blood cells in a healthy context, and how this process is perturbed in common blood disorders.
MRC MHU includes 14 research teams with over 140 scientists who share a common goal, to improve the prognosis of patients with inherited and acquired blood diseases.
This is an exciting time for the field of haematology. The -omics revolution is enabling scientists to unravel the complex molecular processes governing biology at unprecedented speed. At the MRC MHU our teams are committed to applying such cutting-edge techniques to better understand the molecular basis of blood diseases, and to develop treatments to improve the lives of patients. - Professor KJ Patel
Latest publications
TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate
Journal article
Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111
FINE-EM-seq: a rapid isothermal amplification method enabling comprehensive methylome profiling of zebrafish early embryos
Journal article
Ding C. et al, (2026), Cell Insight, 5, 100324 - 100324
Basophils drive the resolution and promote wound healing in adult and aged mice.
Journal article
Bex J. et al, (2026), J Exp Med, 223
Chromosomal Rearrangements Identified in Three Additional Patients With Generalized Congenital Hypertrichosis With Gingival Hyperplasia Involving the 17q24.2-q24.3 Locus.
Journal article
Tenorio-Castano J. et al, (2026), Clin Genet, 109, 904 - 911
Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study.
Journal article
Attfield KE. et al, (2026), Lancet Neurol, 25, 482 - 491